Drug Type Dual payload Antibody drug conjugate (Dual payload ADC) |
Synonyms CD276靶向双载荷ADC(OSU) |
Target |
Action inhibitors |
Mechanism CD276 inhibitors(CD276 antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | United States | 22 Mar 2024 | |
Triple Negative Breast Cancer | Preclinical | United States | 22 Mar 2024 |